Company Directory / research

Forge Biologics logo

PrivateFor profitresearchColumbus, United States

Forge Biologics

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Founded
2020
6 years ago
Staff
251-500
band, as listed
Followers
-
on LinkedIn
Funding
$330M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

251-500 people: larger than 92% of companies with a size listed

Age

202019002026

6 years old.

Reach

Website ranked #2,953,405 in the world for traffic, about 5k visits a month.

What it does

BiotechnologyHealth CareMedicalTherapeutics

Funding, as listed

$330M currency not stated

  • Rounds5
  • LatestSeries c, Sept 2022
  • Investors9, 6 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersErandi De Silva, Jaysson Eicholtz, Timothy J Miller
Acquisitions made1

Every detail we hold

Everything the source datasets list about Forge Biologics, field by field. Contact details are held but never shown.

The company

Name
Forge Biologics
Type
For profit
Status
Private
Founded
2020
Founders
Erandi De Silva, Jaysson Eicholtz, Timothy J Miller
Industry
research
Categories
Biotechnology, Health Care, Medical, Therapeutics

Where

City
Columbus
Country
United States
Markets
Great Lakes, Midwestern US

Size and reach

Staff band
251-500
Web traffic rank
#2,953,405
Monthly web visits
5,330

Funding, as listed

Total
330,000,000 (currency not stated)
Rounds
5
Latest round
Series c
Latest round date
Sept 2022
Investors
9
Lead investors
6
Listing status
private

Corporate family

Acquisitions made
1

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Forge Biologics may be growing as evidenced by its acquisition by a Japanese firm for $620 million, which indicates a significant valuation and interest from larger entities in the biotechnology and therapeutics industry. The acquisition by Ajinomoto, a company looking to boost its gene therapy capabilities, suggests that Forge Biologics has developed valuable assets and expertise in this field. Furthermore, the repeated mention of the acquisition across multiple news sources underscores the importance and impact of this event for Forge Biologics.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.